Le Lézard
Classified in: Health
Subjects: STP, AVO

AANP President urges Senate to Ensure Health Care Legislation Upholds Patient Protections, Coverage for Pre-existing Conditions


AUSTIN, Texas, Sept. 22, 2017 /PRNewswire-USNewswire/ -- The following statement is being issued by AANP President Joyce Knestrick, PhD, C-FNP, FAANP:

"As the Senate moves closer to action on health care reform, the American Association of Nurse Practitioners (AANP) urges Senators to take a measured approach ensuring that any final legislation protects patient access to Medicaid, Medicare and other programs that cover the cost of care. There are more than 234,000 nurse practitioners (NPs) delivering health care to patients throughout the country. Currently, three of four NPs treat Medicare beneficiaries, and 78 percent see Medicaid patients. As this process moves forward, proposals must protect affordable coverage regardless of pre-existing conditions, uphold the principles of essential benefits, safeguard patients' access to the health care provider of their choice, including nurse practitioners, and strengthen the health care workforce while bringing greater overall efficiency to the health care system."

SOURCE American Association of Nurse Practitioners


These press releases may also interest you

at 02:17
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human...

at 02:05
Genflow...

at 02:00
Leading scientists, philanthropists, and policymakers from around the world are coming together in Denmark at the Global Science Summit, hosted by the Novo Nordisk Foundation as part of the organisation's 100-year anniversary. The goal is to explore...

at 01:00
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement clears path for launch of Jubbonti® and Wyost® on...

at 00:30
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology...

at 00:00
The Riverside Company, a global private investor focused on the smaller end of the middle market, has closed the acquisition of Arbeidsmiljř og Energiteknikk AS (AET), a Norwegian distributor of third-party consumables and laboratory / cleaning...



News published on and distributed by: